search
Back to results

Fluid unLoading On Weaning (FLOW) (FLOW)

Primary Purpose

Weaning Failure, Fluid Overload, Cardiac Failure Acute

Status
Unknown status
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
Fluid depletion strategy
Sponsored by
Pontificia Universidad Catolica de Chile
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Weaning Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Mechanical ventilation for >24 hours and <7 days
  2. Patients who on the daily evaluation to assess their potential for weaning present fluid overload and, in consequence, require fluid depletion before the spontaneous breathing trial
  3. Clinical condition resolving or hemodynamically stable condition with acceptable ventilatory status that allows an spontaneous breathing trial according to attending's criteria.

Exclusion Criteria:

  1. Pregnancy
  2. Do-not-resuscitate status
  3. Child B or C liver cirrhosis
  4. Circulatory instability
  5. Acute coronary syndrome
  6. Active bleeding
  7. Severe concomitant acute respiratory distress syndrome
  8. Malnutrition
  9. Muscle weakness severe enough to be considered by itself a risk for weaning failure
  10. Patient should be excluded based on the opinion of the clinician/investigator (documented reason)

Sites / Locations

  • Hospital Clínico UC CHRISTUSRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Fluid Balance Depletive Strategy Group

Preload Responsiveness Depletive Strategy Group

Arm Description

Patients with fluid overload under a depletive strategy to attain a predetermined negative balance

Patients with fluid overload under a depletive strategy to attain a state of preload responsiveness

Outcomes

Primary Outcome Measures

Proportion of patients on each study group presenting weaning-induced pulmonary edema or weaning failure from cardiovascular origin
Development of signs of cardiac failure and acute pulmonary edema during the spontaneous breathing trial.
Mean and standard deviation of T time between the starting of fluid depletion and consolidated weaning from mechanical ventilation on each study group.
Time between the starting of fluid depletion and consolidated weaning from mechanical ventilation, measured in hours and days.

Secondary Outcome Measures

Proportion of patients on each study group presenting weaning-induced global and regional hypoperfusion (lactate, capillary refill time, ScvO2, dCO2)
Development of clinical and laboratory signs of global and regional hypoperfusion due to depletive measures.
Proportion of patients on each study group presenting depletion-induced renal dysfunction assessed by renal stress biomarkers variation.
Development of laboratory signs of renal compromise due to fluid depletion
Proportion of patients on each study group presenting depletion-induced acid-base and electrolyte disturbances.
Development of laboratory signs of acid-base and electrolyte derangements due to fluid depletion.

Full Information

First Posted
July 29, 2020
Last Updated
September 3, 2021
Sponsor
Pontificia Universidad Catolica de Chile
search

1. Study Identification

Unique Protocol Identification Number
NCT04496583
Brief Title
Fluid unLoading On Weaning (FLOW)
Acronym
FLOW
Official Title
Preload Responsiveness as a Signal to Start an Spontaneous Breathing Trial in Mechanically Ventilated Critically Ill Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
June 2023 (Anticipated)
Study Completion Date
June 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pontificia Universidad Catolica de Chile

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if testing preload responsiveness, the normal physiologic state that means that changes in preload determine changes in cardiac output, allows an earlier and physiologically safer weaning from mechanical ventilation in critically ill patients with fluid overload, when compared to a strategy of fluid removal aimed at obtaining a predetermined negative fluid balance.
Detailed Description
Fluid overload is a state of global body accumulation of fluids with a deleterious impact in organ function. This condition is frequently found in critically ill patients after acute resuscitation. Its adverse impact is well demonstrated on weaning-induced heart failure, pulmonary and visceral edema, intraabdominal hypertension, etc., which results in longer mechanical ventilation and length of stay, and worse clinical outcomes. Despite these well-known facts, there are no guidelines on how to implement depletive strategies on this phase. The usual approach is to set in advance a desired negative fluid balance for the upcoming days, initiating diuretics or ultrafiltration in preparation for weaning from mechanical ventilation. Unfortunately, this strategy frequently results in excessive and detrimental fluid removal. A more physiologic approach to guide fluid removal is testing preload responsiveness, which is the normal physiologic state, and means that changes in preload determine changes in cardiac output, with mild or null increment in filling pressures. In contrast, preload unresponsiveness corresponds to a state in which preload increases do not increase stroke volume but produce large increments in filling pressures. This altered state is usually present in patients with fluid overload. Preload responsiveness can be tested routinely in the ICU by assessing the interactions between preload and cardiac output. Now, in usual clinical practice, weaning from mechanical ventilation is accomplished through a process called the spontaneous breathing trial (SBT), which is a standardized test to mimic the real conditions of breathing without the ventilator, before extubation. One-third of patients fail the initial SBT, which determines a prolonged or difficult weaning and longer stay on mechanical ventilation. Importantly, one of the main determinants of this problem is fluid overload. The pathophysiologic explanation lays in that when switching from positive pressure ventilation to spontaneous breathing, intrathoracic pressure goes from being steadily positive across the ventilatory cycle to markedly negative, promoting increased preload and impeding left ventricular ejection, and this phenomenon is associated to preload unresponsiveness. Interestingly, in most patients with fluid overload, preload responsiveness can be restored just a few hours after starting fluid removal, while modifying fluid balance may take several days. Notably, some patients may persist with preload unresponsiveness even after achieving significant fluid removal. The investigators hypothesized that in mechanically ventilated patients with fluid overload, a fluid removal strategy aimed at attaining a state of preload responsiveness associates with a decreased incidence of weaning failure from cardiovascular origin, shorter weaning time, and less depletion-induced hypoperfusion events, metabolic derangements and kidney stress compared to patients depleted with a fluid removal strategy aimed at obtaining a predetermined negative fluid balance. To confirm this hypothesis, the investigators propose a prospective randomized study on 46 critically ill mechanically ventilated patients with fluid overload, comparing these two strategies of depletion and their impact on weaning development and other related systemic functions. Throughout all the protocol, patients will receive general monitoring and management according to ICU standards, plus protocol-specific monitoring that will be added since randomization and before and after SBT attempts, for up to 72 h. Patients will be followed-up for 28 days. If the investigators' hypothesis is confirmed, it may generate a change in the paradigm of managing fluid overload in critically ill patients, since the physiologic endpoint preload responsiveness may suffice as the valid target and safety parameter to appropriately discontinue mechanical ventilation, shortening the days on mechanical ventilation, the ICU length of stay, and many other costs associated, among additional benefits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weaning Failure, Fluid Overload, Cardiac Failure Acute

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized prospective controlled study of parallel groups
Masking
None (Open Label)
Allocation
Randomized
Enrollment
46 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Fluid Balance Depletive Strategy Group
Arm Type
Active Comparator
Arm Description
Patients with fluid overload under a depletive strategy to attain a predetermined negative balance
Arm Title
Preload Responsiveness Depletive Strategy Group
Arm Type
Experimental
Arm Description
Patients with fluid overload under a depletive strategy to attain a state of preload responsiveness
Intervention Type
Other
Intervention Name(s)
Fluid depletion strategy
Intervention Description
The fluid depletion strategy will be individualized depending on the response to the standardized furosemide test (one-time dose of 1.0 or 1.5 mg/kg depending on prior furosemide-exposure) with a urinary output (UO) cutoff of 200 ml at 2 hours. The desired depletion endpoint will be targeted by using diuretics (40 mg q6h iv initially, adjusting dose by UO) or ultrafiltration (UF) if UO <200 ml/2h
Primary Outcome Measure Information:
Title
Proportion of patients on each study group presenting weaning-induced pulmonary edema or weaning failure from cardiovascular origin
Description
Development of signs of cardiac failure and acute pulmonary edema during the spontaneous breathing trial.
Time Frame
72 hours
Title
Mean and standard deviation of T time between the starting of fluid depletion and consolidated weaning from mechanical ventilation on each study group.
Description
Time between the starting of fluid depletion and consolidated weaning from mechanical ventilation, measured in hours and days.
Time Frame
7 days
Secondary Outcome Measure Information:
Title
Proportion of patients on each study group presenting weaning-induced global and regional hypoperfusion (lactate, capillary refill time, ScvO2, dCO2)
Description
Development of clinical and laboratory signs of global and regional hypoperfusion due to depletive measures.
Time Frame
72 hours
Title
Proportion of patients on each study group presenting depletion-induced renal dysfunction assessed by renal stress biomarkers variation.
Description
Development of laboratory signs of renal compromise due to fluid depletion
Time Frame
72 hours
Title
Proportion of patients on each study group presenting depletion-induced acid-base and electrolyte disturbances.
Description
Development of laboratory signs of acid-base and electrolyte derangements due to fluid depletion.
Time Frame
72 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Mechanical ventilation for >24 hours and <7 days Patients who on the daily evaluation to assess their potential for weaning present fluid overload and, in consequence, require fluid depletion before the spontaneous breathing trial Clinical condition resolving or hemodynamically stable condition with acceptable ventilatory status that allows an spontaneous breathing trial according to attending's criteria. Exclusion Criteria: Pregnancy Do-not-resuscitate status Child B or C liver cirrhosis Circulatory instability Acute coronary syndrome Active bleeding Severe concomitant acute respiratory distress syndrome Malnutrition Muscle weakness severe enough to be considered by itself a risk for weaning failure Patient should be excluded based on the opinion of the clinician/investigator (documented reason)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eduardo Kattan, MD, MSc
Phone
+56994793024
Email
e.kattan@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Ricardo Castro
Phone
+56973986588
Email
rcastro@ucchristus.cl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ricardo Castro, MD, MPH
Organizational Affiliation
School of Medicine, Pontificia Universidad Católica de Chile
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Clínico UC CHRISTUS
City
Santiago
State/Province
RM
ZIP/Postal Code
8330077
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
RICARDO CASTRO, MD, MPH
Email
rcastro.med@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Fluid unLoading On Weaning (FLOW)

We'll reach out to this number within 24 hrs